On the occasion of the publication of its quarterly results, Walgreens Boots Alliance has lowered its target range for adjusted EPS for fiscal 2023-24 to between $3.20 and $3.35, compared with the previous estimate of $3.20 to $3.50. The drugstore chain justifies this revision by citing 'a difficult retail environment, the anticipated winding down of the sale-leaseback program and lower earnings'.

The drugstore chain justifies this revision by "a difficult retail environment in the United States, the anticipated winding down of the sale-leaseback program and lower earnings attributable to sales of Cencora shares".

In its second accounting quarter, it incurred a loss of $6.85 per share on goodwill impairment on Village®, but its adjusted EPS rose by 3.4% to $1.20, on sales up 6.3% to 37.1 billion (+5.7% at constant exchange rates).

Copyright (c) 2024 CercleFinance.com. All rights reserved.